Recombinant CD37 (Naratuximab Biosimilar) antibody

Catalog No. ABIN7538072

This Humanized Chimeric antibody specifically detects CD37 (Naratuximab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) antibody (ABIN7538072)

Target: CD37 (Naratuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD37 (Naratuximab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CD37 (Naratuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD37 (Naratuximab Biosimilar)

Target: CD37 (Naratuximab Biosimilar)

Background: Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.

CAS-No: 1622327-39-2